Metraipolis › archive › dc_86c464cb0440
Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials — Europe PMC PMID:42344814
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42344814
- DOI
- 10.7759/cureus.109528
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:17:40.879Z
- SHA-256 of the archived text
3a98265e002e56d8113e663c6547237086fb8c3c6b90003eef02cd1bc30b9b53- Stable URL of this page
https://metraipolis.com/documento/dc_86c464cb0440
How to cite
Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials — Europe PMC PMID:42344814 — Europe PMC (en), https://europepmc.org/article/MED/42344814 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_86c464cb0440 (Metraipolis archive dc_86c464cb0440, sha256 3a98265e002e56d8113e663c6547237086fb8c3c6b90003eef02cd1bc30b9b53)
BibTeX
@misc{dc86c464cb0440,
title = {Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials — Europe PMC PMID:42344814},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42344814},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_86c464cb0440; sha256 3a98265e002e56d8113e663c6547237086fb8c3c6b90003eef02cd1bc30b9b53},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344814. Agents can read the archived copy with the MCP tool read_document.